LindsayAnne(Magura)ReinMD

Myeloproliferative Disorder Hematology-Oncology

Physician

Dr. Rein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Duke University HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014
Duke University HospitalResidency, Internal Medicine, 2008 - 2011
University of North Dakota School of Medicine and Health SciencesClass of 2008

PubMed

39 citations
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Aaron T Gerds, Jason Gotlib, Haris Ali, Prithviraj Bose, Andrew Dunbar
Journal of the National Comprehensive Cancer Network. 2022-09-01
8 citations
The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/...
Barry Paul, Yue Zhao, Gavin Loitsch, Daniel Feinberg, Parker Mathews
Cancer Medicine. 2020-07-06
17 citations
Statin use and need for therapy in chronic lymphocytic leukemia
Daphne R. Friedman, Lindsay A Magura, Holly A C Warren, Jeremy D Harrison, Louis F. Diehl
Leukemia & Lymphoma. 2010-12-06

Lectures

Special Symposium on ASH-Supported Researchers
60th American Society of Hematology Annual Meeting - 12/3/2018
Special Symposium on ASH-Supported Researchers
60th American Society of Hematology Annual Meeting - 12/1/2018

What's Your Approach? Treating MyelofibrosisAugust 7th, 2024
OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesApril 25th, 2019
Risk Stratification in Myelofibrosis: Which Model Should You Use?July 6th, 2024